• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Environ Pollut . The association of airborne particulate matter and benzo[a]pyrene with the clinical course of COVID-19 in patients hospitalized in

tetano

Editor, Senior Moderator
Environ Pollut


. 2022 May 14;119469.
doi: 10.1016/j.envpol.2022.119469. Online ahead of print.
The association of airborne particulate matter and benzo[a]pyrene with the clinical course of COVID-19 in patients hospitalized in Poland


Piotr Rzymski[SUP] 1 [/SUP], Barbara Poniedziałek[SUP] 2 [/SUP], Joanna Rosińska[SUP] 2 [/SUP], Magdalena Rogalska[SUP] 3 [/SUP], Dorota Zarębska-Michaluk[SUP] 4 [/SUP], Marta Rorat[SUP] 5 [/SUP], Anna Moniuszko-Malinowska[SUP] 6 [/SUP], Beata Lorenc[SUP] 7 [/SUP], Dorota Kozielewicz[SUP] 8 [/SUP], Anna Piekarska[SUP] 9 [/SUP], Katarzyna Sikorska[SUP] 10 [/SUP], Anna Dworzańska[SUP] 11 [/SUP], Beata Bolewska[SUP] 12 [/SUP], Grzegorz Angielski[SUP] 13 [/SUP], Justyna Kowalska[SUP] 14 [/SUP], Regina Podlasin[SUP] 15 [/SUP], Barbara Oczko-Grzesik[SUP] 16 [/SUP], Włodzimierz Mazur[SUP] 17 [/SUP], Aleksandra Szymczak[SUP] 18 [/SUP], Robert Flisiak[SUP] 3 [/SUP]



Affiliations

Abstract

Air pollution can adversely affect the immune response and increase the severity of the viral disease. The present study aimed to explore the relationship between symptomatology, clinical course, and inflammation markers of adult patients with coronavirus disease 2019 (COVID-19) hospitalized in Poland (n = 4432) and air pollution levels, i.e., mean 24 h and max 24 h level of benzo(a)pyrene (B(a)P) and particulate matter <10 μm (PM[SUB]10[/SUB]) and <2.5 μm (PM[SUB]2.5[/SUB]) during a week before their hospitalization. Exposures to PM[SUB]2.5[/SUB] and B(a)P exceeding the limits were associated with higher odds of early respiratory symptoms of COVID-19 and hyperinflammatory state: interleukin-6 > 100 pg/mL, procalcitonin >0.25 ng/mL, and white blood cells count >11 × 10[SUP]3[/SUP]/mL. Except for the mean 24 h PM[SUB]10[/SUB] level, the exceedance of other air pollution parameters was associated with increased odds for oxygen saturation <90%. Exposure to elevated PM[SUB]2.5[/SUB] and B(a)P levels increased the odds of oxygen therapy and death. This study evidences that worse air quality is related to increased severity of COVID-19 and worse outcome in hospitalized patients. Mitigating air pollution shall be an integral part of measures undertaken to decrease the disease burden during a pandemic of viral respiratory illness.

Keywords: Epidemiology; Inflammation markers; Particulate matter; Severe COVID-19; benzo(a)pyrene.
 
Back
Top Bottom